• Molecular NameSulfoxone
  • SynonymAdesulfone Sodium; Aldesulfone Sodium; Sodium Aldesulphone; Sodium Sulfoxone; Sulfoxone Sodium
  • Weight404.488
  • Drugbank_IDDB01145
  • ACS_NO144-75-2, 144-76-3
  • Show 3D model
  • LogP (experiment)-1.064
  • LogP (predicted, AB/LogP v2.0)-0.56
  • pkaN/A
  • LogD (pH=7, predicted)-5.56
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.39
  • LogSw (predicted, AB/LogsW2.0)0.2
  • Sw (mg/ml) (predicted, ACD/Labs)1.34
  • No.of HBond Donors4
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds8
  • TPSA179.6
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA water-soluble sulfone used as an antileprosy drug. It has been used with limited success in the treatment of dermatitis herpetiformis.
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding69.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life3~8 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityOral, rat LD50: 7000 mg/kg
  • LD50 (rat)LD50=7000 mg/kg
  • LD50 (mouse)N/A